Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

NCT02114502 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Carfilzomib
DRUG: SAHA
DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Melphalan
PROCEDURE: Stem Cell Transplant (SCT)
DRUG: Palifermin
DRUG: Dexamethasone
DRUG: Caphosol
DRUG: Glutamine
DRUG: Pyridoxine

Sponsor

M.D. Anderson Cancer Center